NB, If the share price of cannabis hotshot CRONOS gets a bit of a pummelling over the next few days - there should be no rub off for ECS or any others in the cannabis sector. The issue is CHRONOS specific.CDA, their big prescribing portal, has just been told to discontinue their most popular feature, the Special Treatment program. (about 3 hrs ago) This comes only a month after their limit-pushing "open script" scheme was similarly shuttered by the TGA last month.
The MC forums are full of CDA clients screaming blue bloody murder as we speak. I am so glad not to be invested in the clinic side of the industry. They had a privileged near-monopoly on easy access for a while - but that is comimg to an end. GP's are steadily going to replace these expensive, restrictive, anachronisms. (imo only)
